Glenmark Pharmaceuticals launches TEVIMBRA in India for advanced lung and esophageal cancer treatment
Glenmark Pharmaceuticals has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its entry into the immuno-oncology space. This anti-PD-1 monoclonal antibody, developed by global oncology firm BeiGene (now BeOne Medicines), is approved for the treatment of advanced non-small cell lung cancer (NSCLC) and esophageal squamous cell carcinoma (ESCC).
The drug is designed to restore T-cell function and minimize off-target immune suppression, having shown strong efficacy and safety in global trials. Already approved in over 46 countries including the U.S. and EU, TEVIMBRA has been used in treating more than 1.5 million patients worldwide.
Glenmark's President Alok Malik stated that the company is committed to transforming cancer care in India by making cutting-edge immunotherapies accessible. The launch comes at a time when cancer incidence in India is sharply rising, especially NSCLC and ESCC which dominate their respective cancer types in the country.
This milestone aligns with Glenmark's broader ambition to build a globally benchmarked oncology portfolio, adding to its existing focus areas of respiratory and dermatology.
Disclaimer: This content is for informational purposes only and not a substitute for professional medical advice.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 hours ago
- Yahoo
BeOne Medicines Ltd. (ONC) Wins EU Nod for Tevimbra
We recently compiled a list of BeOne Medicines Ltd. stands ninth on our list. BeOne Medicines Ltd. (NASDAQ:ONC), formerly BeiGene, is a global oncology company now headquartered in Switzerland following its May 2025 redomiciliation. The strategic move enhances the company's access to European biotech networks and regulatory alignment, supporting its mission to lead in cancer innovation. With operations in over 45 countries and a pipeline of 50+ investigational assets, the business is rapidly expanding its R&D and clinical presence. A major milestone for BeOne Medicines Ltd. (NASDAQ:ONC) this year was the European Commission's approval of Tevimbra (tislelizumab) for multiple indications, including extensive-stage small cell lung cancer and nasopharyngeal carcinoma, further cementing its role in immuno-oncology. Tevimbra is already FDA-approved for esophageal cancer, and continued regulatory momentum is expected. In hematology, the corporation showcased significant advances at the 2025 EHA Congress. Sonrotoclax (a BCL2 inhibitor) and BGB-16673 (a first-in-class BTK degrader) delivered promising results in treating resistant forms of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), advancing toward Phase 3 trials. Meanwhile, BRUKINSA (zanubrutinib) remains a core therapy, demonstrating superior outcomes compared to ibrutinib. A pharmacy worker distributing prescription medicines to patientsreceiving treatment for oncology, cardiovascular, renal, metabolism and respiratory diseases. BeOne Medicines Ltd. (NASDAQ:ONC) also made strides in pipeline growth, advancing 13 new molecules into clinical trials in 2024 alone. With 170+ global trials and over 25,000 patients enrolled, its 'Fast to Proof-of-Concept' strategy accelerates timelines and patient access. In June 2025, a licensing deal with Neowise Biotechnology expanded the business's efforts in next-gen cell therapies, particularly TCR-based platforms.\ While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
2 days ago
- Business Upturn
Kotak Mahindra Bank Q1 results: Net profit down 47% YoY to Rs 3,282 crore, GNPA at 1.48% vs 1.39% QoQ
Kotak Mahindra Bank reported a 47.5% year-on-year (YoY) decline in net profit for the quarter ended June 30, 2025, with Q1 FY26 profit standing at Rs 3,281.68 crore compared to Rs 6,249.82 crore in Q1 FY25. The sharp fall is primarily due to the absence of exceptional gains booked in the same quarter last year. Net Interest Income (NII) grew 6% YoY to Rs 7,259 crore from Rs 6,843 crore, reflecting steady growth in lending and core banking operations. Total income rose to Rs 16,916 crore from Rs 15,675 crore YoY. Operating profit (before provisions) rose to Rs 5,563.69 crore from Rs 5,254.11 crore in the previous year. Provisions and contingencies, however, jumped to Rs 1,207.76 crore from Rs 578.48 crore YoY, impacting the bank's profitability. Asset quality weakened slightly: Gross NPA: Rs 6,637.70 crore (1.48%) vs Rs 5,477.15 crore (1.39%) QoQ Net NPA: Rs 1,530.93 crore (0.34%) vs Rs 1,376.33 crore (0.35%) QoQ Despite steady growth in core income, the YoY profit decline was driven by the high base effect of last year's Rs 3,519.90 crore exceptional gain. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
CNBC
2 days ago
- CNBC
Southwest offers new 100,000-point bonus as it revamps its credit cards
Southwest Airline's seating policy isn't the only thing that's changing; the airline and Chase announced updates to the Southwest Rapid Rewards credit cards — adding enhanced benefits like pre-flight seat selection and early boarding, new earning categories and a welcome bonus any loyal Southwest flyer would love. For a limited time, now through Sep. 17, new Southwest Rapid Rewards Priority, Premier or Plus consumer credit cardmembers can earn 100,000 bonus points after spending $4,000 in the first five months from account opening. This is double the previous welcome bonus of 50,000 points, and it marks Southwest's best points offer this year. Along with the additional perks come other costs: card annual fees are increasing and Southwest will be expiring a few current benefits and reward categories. Here's a breakdown by card: Offers in this section are from affiliate partners and selected based on a combination of engagement, product relevance, compensation, and consistent Saint offers three packages for credit repair services and a 90-day money-back guarantee for services. It has received an A rating and is accredited by the Better Business Credit People's Credit Report Repair service is relatively affordable compared to other programs in the space. Even the most basic package (the standard package) includes unlimited challenges to all three credit bureaus. Upgrading to the premium package includes escalated disputes and monthly credit score reports and score refreshes. On Chase's site On Chase's site Good to Excellent670–850 19.99% - 28.49% variable $99 Earn 100,000 points. See rates and fees. Terms apply. Member FDIC. Read our Southwest Rapid Rewards® Plus Credit Card review. The Southwest Rapid Rewards® Plus Credit Card is an affordable card that makes sense for the occasional Southwest $5 or 5% of the amount of each transfer, whichever is greater The Southwest Rapid Rewards Plus annual fee is rising from $69 to $99, a $30 hike. Good to Excellent670–850 20.49% - 27.49% variable $149 Earn 100,000 bonus points. Terms apply. Information about the Southwest Rapid Rewards® Premier Credit Card has been collected independently by Select and has not been reviewed or provided by the issuer of the card prior to publication. Read our Southwest Rapid Rewards Premier Credit Card review The Southwest Rapid Rewards® Premier Credit Card is Southwest's mid-tier card and is valuable if you regularly travel to or from destinations Southwest serves.5%, minimum $5 The Southwest Rapid Rewards Premier annual fee is increasing from $99 to $149, a $50 rise. On Chase's site On Chase's site Good to Excellent670–850 19.99% - 28.49% variable $229 Earn 100,000 points. See rates and fees. Terms apply. Member FDIC. Read our Southwest Rapid Rewards® Priority Credit Card review. The Southwest Rapid Rewards® Priority Credit Card is a perfect fit for serious Southwest fans who can easily maximize its benefits like upgraded boardings and an annual travel Southwest Rapid Rewards Priority annual fee is being hiked from $149 to $229, an $80 increase. Offers in this section are from affiliate partners and selected based on a combination of engagement, product relevance, compensation, and consistent availability. Good to Excellent670–850Earn 75,000 bonus points On Chase's site See rates and fees. Terms apply. Good to Excellent670–850Earn 75,000 miles Terms apply. The Southwest Rapid Rewards Plus Business is currently unavailable for new users, but carries a $99 annual fee. On Chase's site On Chase's site You can earn unlimited tier qualifying points for spending with this card. Good to Excellent670–850 19.99% - 28.49% variable $149 Earn 60,000 points See rates and fees. Terms apply. Member FDIC. Read our Southwest Rapid Rewards Premier Business Credit Card review The Southwest® Rapid Rewards® Premier Business Credit Card can help your business save on Southwest travel but offers less value for other $5 or 5% of the amount of each transfer, whichever is greater The Southwest Rapid Rewards Premier Business annual fee is increasing from $99 to $149, a $50 rise. On Chase's site On Chase's site Every account anniversary year you'll receive a 9,000-point bonus. Good to Excellent670–850 19.99% - 28.49% variable $299 Earn 80,000 points See rates and fees. Terms apply. Member FDIC. The Southwest® Rapid Rewards® Performance Business Credit Card is Southwest's most premium business credit card and can be incredibly rewarding for frequent flyers, especially those chasing the Southwest Companion Pass or other Southwest elite $5 or 5% of the amount of each transfer, whichever is greater The Southwest Rapid Rewards Performance Business annual fee is being bumped up from $199 to $299, a $100 increase. If you fly on Southwest with some frequency, chances are you'll be able to get some extra value out of these cards. Not only will you have opportunities when you book with Southwest, but with the addition of new rewards categories, you have more opportunities to earn Southwest Rapid Rewards, which can be redeemed for valuable rewards like flights and hotel stays. The Southwest cards are losing some benefits in categories like transit, internet and phone services, plus increasing annual fees. While a Southwest credit card may still make sense if you frequently travel with Southwest, it might be harder to earn rewards points if you don't often spend in the new rewards categories. Money matters — so make the most of it. Get expert tips, strategies, news and everything else you need to maximize your money, right to your inbox. Sign up here. At CNBC Select, our mission is to provide our readers with high-quality service journalism and comprehensive consumer advice so they can make informed decisions with their money. Every credit card article is based on rigorous reporting by our team of expert writers and editors with extensive knowledge of credit card products. While CNBC Select earns a commission from affiliate partners on many offers and links, we create all our content without input from our commercial team or any outside third parties, and we pride ourselves on our journalistic standards and ethics.
